Skandinaviska Enskilda Banken AB (publ) - CORCEPT THERAPEUTICS INC ownership

CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 231 filers reported holding CORCEPT THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 0.94 and the average weighting 0.1%.

Quarter-by-quarter ownership
Skandinaviska Enskilda Banken AB (publ) ownership history of CORCEPT THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$1,188
+1.5%
43,600
-17.1%
0.01%0.0%
Q2 2023$1,170
-49.1%
52,600
-50.4%
0.01%
-50.0%
Q1 2023$2,298
-99.6%
106,100
+365.4%
0.02%
+300.0%
Q1 2021$542,000
-22.3%
22,800
-14.6%
0.00%
-20.0%
Q4 2020$698,000
-61.4%
26,700
-74.3%
0.01%
-61.5%
Q3 2020$1,808,000
+49.9%
103,900
+44.9%
0.01%
+30.0%
Q2 2020$1,206,00071,7000.01%
Other shareholders
CORCEPT THERAPEUTICS INC shareholders Q2 2020
NameSharesValueWeighting ↓
INGALLS & SNYDER LLC 6,951,077$178,226,0009.95%
Parallel Advisors, LLC 3,769,455$96,649,0004.45%
Novo Holdings A/S 3,327,768$85,324,0004.07%
TANAKA CAPITAL MANAGEMENT INC 35,539$911,0002.72%
Quantedge Capital Pte Ltd 243,712$6,249,0001.93%
S&T BANK/PA 349,456$8,960,0001.73%
Birchview Capital, LP 50,000$1,282,0000.90%
Bridge City Capital, LLC 61,254$1,571,0000.86%
FAS Wealth Partners, Inc. 299,576$7,681,0000.85%
AJ WEALTH STRATEGIES, LLC 509,934$13,075,0000.76%
View complete list of CORCEPT THERAPEUTICS INC shareholders